Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03502798 · ClinicalTrials.gov registry record · NA
Coherence Imaging of the Cervical Epithelium With Scanning a/LCI
A NA study of Cervical Dysplasia, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 2
- Study locations
NCT03502798 is a NA study of Cervical Dysplasia that has completed, run by Duke University. The registered enrollment target is 45 participants, below the 543-participant average among 7 other Cervical Dysplasia trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03502798, a NA study of Cervical Dysplasia, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to develop a low coherence interferometry (LCI) endoscopic probe that can examine the cervix for evidence of cervical dysplasia. The device will make optical measurements of the cervix to determine: 1. the difference between two different types of cervical cells: ectocervical cells and endocervical cells. Cervical dysplasia is most likely to occur at the junction between these two types of cells. 2. features of individual cervical cells that indicate whether the cell is normal or abnormal (cervical dysplasia).
Conditions Studied
Interventions
- DEVICE scanning a/LCI
Study Locations (2)
New York
- Jacobi Medical Center - The Bronx
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2018-11-08 |
| Est. Completion | 2020-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03502798
The ClinicalTrials.gov registry entry for NCT03502798 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 543-participant average among 7 other Cervical Dysplasia trials with a reported enrollment target (92% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervical Dysplasia appearing as the primary indexed condition, and to 1 intervention - of which scanning a/LCI is the first listed.
NCT03502798 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, North Carolina.
Frequently Asked Questions
What is clinical trial NCT03502798 about?
NCT03502798 is a clinical study titled "Coherence Imaging of the Cervical Epithelium With Scanning a/LCI". The purpose of this study is to develop a low coherence interferometry (LCI) endoscopic probe that can examine the cervix for evidence of cervical dysplasia. The device will make optical measurements of the cervix to determine: 1. the difference between two different types of cervical cells: ectoce...
What is the current status of trial NCT03502798?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2018-11-08. Estimated completion is 2020-02-14.
What conditions does trial NCT03502798 study?
This clinical trial studies the following conditions: Cervical Dysplasia.
What interventions are being tested in trial NCT03502798?
The interventions under investigation include: scanning a/LCI (DEVICE).
Who is sponsoring clinical trial NCT03502798?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03502798 being conducted?
This trial has 2 study locations across New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers
RECRUITING · NA
-
Smoking Cessation in Women With Gynecological Conditions
COMPLETED · NA
-
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RECRUITING
-
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
RECRUITING · Phase 2
-
REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
COMPLETED · Phase 3
-
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.